Insulin aspart, recombinant Subcutaneous and Lefamulin Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lefamulin Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lefamulin
Brand name: Xenleta
Synonyms: Lefamulin, Lefamulin (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lefamulin Tablets
- Insulin aspart, recombinant Subcutaneous-Leflunomide
- Insulin aspart, recombinant Subcutaneous-Legatrin PM
- Insulin aspart, recombinant Subcutaneous-Lemtrada
- Insulin aspart, recombinant Subcutaneous-Lenalidomide
- Insulin aspart, recombinant Subcutaneous-Lenvatinib
- Lefamulin Injection-Insulin degludec
- Lefamulin Injection-Insulin Degludec (U-100) Prefilled Pens
- Lefamulin Injection-Insulin Degludec (U-100) Vials
- Lefamulin Injection-Insulin Degludec (U-200) Prefilled Pens
- Lefamulin Injection-Insulin degludec and liraglutide
- Lefamulin Injection-Insulin degludec and liraglutide Subcutaneous